Literature DB >> 8415658

The human gastrin/cholecystokinin type B receptor gene: alternative splice donor site in exon 4 generates two variant mRNAs.

I Song1, D R Brown, R N Wiltshire, I Gantz, J M Trent, T Yamada.   

Abstract

Gastrin and its carboxyl-terminal homolog cholecystokinin (CCK) exert a variety of biological actions in the brain and gastrointestinal tract that are mediated in part through one or more G protein-coupled receptors which exhibit similar affinity for both peptides. Genomic clones encoding a human gastrin/CCKB receptor were isolated by screening a human EMBL phage library with a partial-length DNA fragment which was based on the nucleotide sequence of the canine gastrin receptor. The gene contained a 1356-bp open reading frame consisting of five exons interrupted by 4 introns and was assigned to human chromosome 11p15.4. A region of exon 4, which encodes a portion of the putative third intracellular loop, appears to be alternatively spliced to yield two different mRNAs, one containing (452 amino acids; long isoform) and the other lacking (447 amino acids; short isoform) the pentapeptide sequence Gly-Gly-Ala-Gly-Pro. The two receptor isoforms may contribute to functional differences in gastrin- and CCK-mediated signal transduction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8415658      PMCID: PMC47506          DOI: 10.1073/pnas.90.19.9085

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Transcription mediated by a cAMP-responsive promoter element is reduced upon activation of dopamine D2 receptors.

Authors:  J P Montmayeur; E Borrelli
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

2.  Alternative splicing directs the expression of two D2 dopamine receptor isoforms.

Authors:  B Giros; P Sokoloff; M P Martres; J F Riou; L J Emorine; J C Schwartz
Journal:  Nature       Date:  1989 Dec 21-28       Impact factor: 49.962

3.  Multiple D2 dopamine receptors produced by alternative RNA splicing.

Authors:  F J Monsma; L D McVittie; C R Gerfen; L C Mahan; D R Sibley
Journal:  Nature       Date:  1989 Dec 21-28       Impact factor: 49.962

4.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

5.  A simple and very efficient method for generating cDNA libraries.

Authors:  U Gubler; B J Hoffman
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

6.  Distinct cholecystokinin receptors in brain and pancreas.

Authors:  R B Innis; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

7.  Two brain cholecystokinin receptors: implications for behavioral actions.

Authors:  T H Moran; P H Robinson; M S Goldrich; P R McHugh
Journal:  Brain Res       Date:  1986-01-01       Impact factor: 3.252

8.  Distinct receptors for cholecystokinin and gastrin on muscle cells of stomach and gallbladder.

Authors:  J R Grider; G M Makhlouf
Journal:  Am J Physiol       Date:  1990-08

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas.

Authors:  S A Wank; R Harkins; R T Jensen; H Shapira; A de Weerth; T Slattery
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

View more
  21 in total

1.  Pharmacological comparison of the alternatively spliced short and long CCK2 receptors.

Authors:  M F Morton; E A Harper; I A Tavares; N P Shankley
Journal:  Br J Pharmacol       Date:  2003-08-04       Impact factor: 8.739

2.  Differential sensitivity of types 1 and 2 cholecystokinin receptors to membrane cholesterol.

Authors:  Ross M Potter; Kaleeckal G Harikumar; S Vincent Wu; Laurence J Miller
Journal:  J Lipid Res       Date:  2011-10-21       Impact factor: 5.922

3.  Linkage assignment of eleven genes to the porcine genome.

Authors:  Z Hu; G A Rohrer; R T Stone; M Rutherford; M A Osinski; M S Pampusch; M P Murtaugh; D R Brown; C W Beattie
Journal:  Mamm Genome       Date:  1997-08       Impact factor: 2.957

4.  A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancer.

Authors:  Jill P Smith; John F Harms; Gail L Matters; Christopher O McGovern; Francesca M Ruggiero; Jiangang Liao; Kristin K Fino; Emily E Ortega; Evan L Gilius; John A Phillips
Journal:  Cancer Biol Ther       Date:  2012-02-01       Impact factor: 4.742

5.  Thermodynamic analysis of ligands at cholecystokinin CCK2 receptors in rat cerebral cortex.

Authors:  E A Harper; S P Roberts; S B Kalindjian
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

6.  Analysis of variation in L-365,260 competition curves in radioligand binding assays.

Authors:  E A Harper; S P Roberts; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

7.  An 84-kilobase physical map and repeat polymorphisms of the gastrin/cholecystokinin brain receptor region at the junction of chromosome segments 11p15.4 and 15.5.

Authors:  K C O'Briant; S Y Ali; H U Weier; G Bepler
Journal:  Chromosome Res       Date:  1998-08       Impact factor: 5.239

Review 8.  Cholecystokinin receptors.

Authors:  P Boden; M D Hall; J Hughes
Journal:  Cell Mol Neurobiol       Date:  1995-10       Impact factor: 5.046

9.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

10.  Localization of the murine cholecystokinin A and B receptor genes.

Authors:  L C Samuelson; M S Isakoff; K A Lacourse
Journal:  Mamm Genome       Date:  1995-04       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.